{
  "id": 138213,
  "title": "Novo Nordisk Slides as Forecast Boost Fails to Impress",
  "url": "https://urgent.news/2026/08/04/novo-nordisk-slides-as-forecast-boost-fails-to-impress",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-04T16:48:40.000Z",
  "source": {
    "name": "Bloomberg",
    "slug": "bloomberg",
    "url": "https://www.bloomberg.com/news/articles/2026-08-04/novo-nordisk-boosts-forecast-on-soaring-glp-1-sales"
  },
  "original_language": "en",
  "account": null,
  "summary": "Novo Nordisk A/S raised its forecasts for the second time this year, citing higher expectations for its obesity and diabetes drug sales, though the magnitude of the increase failed to impress investors.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}